Valedo® Back Training System From Hocoma Named 2015 CES Innovation Awards Honoree
NORWELL, Mass., Nov. 12, 2014 /PRNewswire/ -- Hocoma, a leader in the development of robotic and sensor-based devices for functional movement therapy, today announced that Valedo®, the company's novel medical device and gaming platform to help back pain sufferers achieve sustained back health, has been named a 2015 CES Innovation Awards Honoree in the wearable technologies category. The CES Innovation Awards, sponsored by the Consumer Electronics Association (CEA)®, is an annual competition honoring outstanding design and engineering in consumer technology products.
Valedo is the first wearable medical device for the low back that combines physical sensors with sophisticated, yet intuitive software to motivate and guide users through fun and interactive exercises. Grounded in movement science and physiotherapy, Valedo helps users improve movement awareness for increased stability and balance, restore motion to vertebral joints, and redevelop deep muscles for enhanced strength. Through consistent use, these movements can help back pain sufferers achieve sustained back health.
"We are honored to be recognized by the CEA with this prestigious award and recognized alongside some of the most innovative new consumer technologies hitting the market," said Frank Menzler, executive vice president of Hocoma in the United States. "Based on technology used in professional rehabilitation and physical therapy settings, Valedo puts the power of back health into the hands of consumers. This cutting-edge new tool motivates users to get moving and we are excited to share it with consumers in the U.S."
Intended for consumers looking for a way to continue the benefits of professional physical therapy at home, as well as for those interested in an alternative, self-help tool, Valedo offers 17 unique movements incorporated into 45 therapeutic and medically beneficial exercises that can be done at home or on the go. Listed with the U.S. Food and Drug Administration (FDA), Valedo will be available for purchase later this year at www.valedotherapy.com for $359. The device is compatible with the iPad 3 and above, iPhone 5 and above and all versions of the iPad mini. The Valedo app is available for free download on the Apple App Store and all new exercises, games and software updates are pushed to users automatically and free of charge.
Valedo will be displayed at the 2015 International CES, which runs Jan. 6-9, 2015, in Las Vegas, Nevada. Honorees will also be displayed at CES Unveiled New York on November 11 and CES Unveiled Las Vegas on January 4. Valedo, along with the rest of the 2015 CES Innovation Honorees, are featured on CESweb.org/Innovation.
Hocoma was set up in 2000 as a spin-off of the Swiss University Hospital Balgrist. The company currently employs more than 170 people at its headquarters in Volketswil near Zurich (Switzerland) and at its subsidiaries in the US, Singapore and Slovenia. Hocoma is the global market leader for developing, manufacturing and marketing of robotic and sensor based devices for functional movement therapy. Therapy solutions support the treatment of neurological patients with movement disorders caused by stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, cerebral palsy or other neurological diseases and injuries as well as low back pain patients. The product range features devices for intensive gait therapy (Lokomat®), functional therapy of the upper extremities (Armeo®), patient mobilization and use in early rehabilitation programs (Erigo®), as well as functional movement therapy for lower back pain (Valedo®) at home and at the therapist. Hocoma products are applied successfully in clinics and research institutes worldwide. The medical technology company has received many technology and entrepreneur awards, including the "Swiss Technology Award" and the "Ernst & Young Entrepreneur of the Year" award. Hocoma generated a turnover of more than 30 million CHF in 2013. Dr. Gery Colombo is the CEO of Hocoma AG.